Gene Symbol | ADORA1 |
Entrez ID | 134 |
Uniprot ID | P30542 |
Description | adenosine A1 receptor |
Chromosomal Location | chr1: 203,090,654-203,167,405 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0000186 |
activation of MAPKK activity |
The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK). |
IEA |
BP |
GO:0001659 |
temperature homeostasis |
A homeostatic process in which an organism modulates its internal body temperature. |
IEA |
BP |
GO:0001666 |
response to hypoxia |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
IEA |
BP |
GO:0001973 |
adenosine receptor signaling pathway |
The series of molecular signals generated as a consequence of a receptor binding to extracellular adenosine and transmitting the signal to a heterotrimeric G-protein complex to initiate a change in cell activity. |
IEA |
BP |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process |
A process carried out by the nervous system that is required for the proper control of respiratory gaseous exchange. This process occurs in the respiratory center of the brain in vertebrates. |
IEA |
BP |
GO:0002674 |
negative regulation of acute inflammatory response |
Any process that stops, prevents, or reduces the frequency, rate, or extent of an acute inflammatory response. |
IEA |
BP |
GO:0002686 |
negative regulation of leukocyte migration |
Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte migration. |
IEA |
BP |
GO:0002793 |
positive regulation of peptide secretion |
Any process that activates or increases the frequency, rate, or extent of peptide secretion. |
IEA |
BP |
GO:0003093 |
regulation of glomerular filtration |
Any process that modulates the frequency, rate or extent of glomerular filtration. Glomerular filtration is the process in which blood is filtered by the glomerulus into the renal tubule. |
IEA |
BP |
GO:0006612 |
protein targeting to membrane |
The process of directing proteins towards a membrane, usually using signals contained within the protein. |
IEA |
BP |
GO:0006909 |
phagocytosis |
An endocytosis process that results in the engulfment of external particulate material by phagocytes. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles. |
TAS |
BP |
GO:0006954 |
inflammatory response |
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
TAS |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
TAS |
BP |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds through inhibition of adenylyl cyclase activity and a subsequent decrease in the concentration of cyclic AMP (cAMP). |
IEA |
BP |
GO:0007267 |
cell-cell signaling |
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions. |
TAS |
BP |
GO:0007399 |
nervous system development |
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state. |
TAS |
BP |
GO:0008285 |
negative regulation of cell proliferation |
Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
IEA |
BP |
GO:0014050 |
negative regulation of glutamate secretion |
Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of glutamate. |
IEA |
BP |
GO:0016042 |
lipid catabolic process |
The chemical reactions and pathways resulting in the breakdown of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. |
IEA |
BP |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic |
Any process that stops, prevents, or reduces the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA). |
IEA |
BP |
GO:0032244 |
positive regulation of nucleoside transport |
Any process that activates or increases the frequency, rate or extent of the directed movement of a nucleoside into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
IEA |
BP |
GO:0032900 |
negative regulation of neurotrophin production |
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of a neurotrophin. |
IEA |
BP |
GO:0035307 |
positive regulation of protein dephosphorylation |
Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a protein. |
IEA |
BP |
GO:0035814 |
negative regulation of renal sodium excretion |
Any process that decreases the amount of sodium excreted in urine over a unit of time. |
IEA |
BP |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep |
Any process that stops, prevents or reduces the duration or quality of non-rapid eye movement (NREM) sleep. |
IEA |
BP |
GO:0043066 |
negative regulation of apoptotic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
IEA |
BP |
GO:0043268 |
positive regulation of potassium ion transport |
Any process that activates or increases the frequency, rate or extent of the directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
IEA |
BP |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity |
Any process that activates or increases the frequency, rate or extent of EGF-activated receptor activity. |
IEA |
BP |
GO:0045776 |
negative regulation of blood pressure |
Any process in which the force of blood traveling through the circulatory system is decreased. |
IEA |
BP |
GO:0045777 |
positive regulation of blood pressure |
Any process in which the force of blood traveling through the circulatory system is increased. |
IEA |
BP |
GO:0045908 |
negative regulation of vasodilation |
Any process that stops, prevents, or reduces the frequency, rate or extent of vasodilation. |
IEA |
BP |
GO:0046888 |
negative regulation of hormone secretion |
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a hormone from a cell. |
IEA |
BP |
GO:0050890 |
cognition |
The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory. |
IEA |
BP |
GO:0050965 |
detection of temperature stimulus involved in sensory perception of pain |
The series of events involved in the perception of pain in which a temperature stimulus is received and converted into a molecular signal. |
IEA |
BP |
GO:0050995 |
negative regulation of lipid catabolic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids. |
IEA |
BP |
GO:0051930 |
regulation of sensory perception of pain |
Any process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal. |
IEA |
BP |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic |
Any process that stops, prevents, or reduces the frequency, rate or extent of glutamatergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate. |
IEA |
BP |
GO:0055118 |
negative regulation of cardiac muscle contraction |
Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac muscle contraction. |
IEA |
BP |
GO:0060079 |
excitatory postsynaptic potential |
A process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential. |
IEA |
BP |
GO:0060087 |
relaxation of vascular smooth muscle |
A process in which the extent of vascular smooth muscle contraction is reduced. Vascular smooth muscle relaxation is mediated via a decrease in the phosphorylation state of myosin light chain. This can be achieved by removal of calcium from the cytoplasm to the sarcoplasmic reticulum lumen through the action of Ca2+ ATPases leading to a decrease myosin light chain kinase activity, and through calcium-independent pathways leading to a increase in myosin light chain phosphatase activity. |
IEA |
BP |
GO:0070256 |
negative regulation of mucus secretion |
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of mucus from a cell or a tissue. |
IEA |
BP |
GO:0097190 |
apoptotic signaling pathway |
A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered. |
TAS |
BP |
GO:1900453 |
negative regulation of long term synaptic depression |
Any process that stops, prevents or reduces the frequency, rate or extent of long term synaptic depression. |
IEA |
CC |
GO:0005783 |
endoplasmic reticulum |
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
IEA |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
TAS |
CC |
GO:0005887 |
integral component of plasma membrane |
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
TAS |
CC |
GO:0014069 |
postsynaptic density |
The postsynaptic density is a region that lies adjacent to the cytoplasmic face of the postsynaptic membrane at an excitatory synapse. It forms an electron-dense disc that consists of a range of proteins with different functions, some of which contact the cytoplasmic domains of ion channels in the postsynaptic membrane. The proteins making up the disc include structural proteins linked to the actin cytoskeleton and signalling machinery, such as protein kinases and phosphatases. |
IEA |
CC |
GO:0016323 |
basolateral plasma membrane |
The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
IEA |
CC |
GO:0030673 |
axolemma |
The portion of the plasma membrane surrounding an axon; it is a specialized trilaminar random mosaic of protein molecules floating within a fluid matrix of highly mobile phospholipid molecules, 7-8 nm in thickness. |
IEA |
CC |
GO:0032279 |
asymmetric synapse |
A type of synapse occurring between an axon and a dendritic spine or dendritic shaft. Asymmetric synapses, the most abundant synapse type in the central nervous system, involve axons that contain predominantly spherical vesicles and contain a thickened postsynaptic density. Most or all synapses of this type are excitatory. |
IEA |
CC |
GO:0042734 |
presynaptic membrane |
A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane. |
IEA |
CC |
GO:0043025 |
neuronal cell body |
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
IEA |
CC |
GO:0043195 |
terminal bouton |
Terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters. The axon terminus is considered to be the whole region of thickening and the terminal bouton is a specialized region of it. |
IEA |
CC |
GO:0043197 |
dendritic spine |
A small, membranous protrusion from a dendrite that forms a postsynaptic compartment - typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable including thin, stubby, mushroom, and branched, with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity. |
IEA |
CC |
GO:0045211 |
postsynaptic membrane |
A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane. |
IEA |
CC |
GO:0048786 |
presynaptic active zone |
A specialized region of the plasma membrane and cell cortex of a presynaptic neuron; encompasses a region of the plasma membrane where synaptic vesicles dock and fuse, and a specialized cortical cytoskeletal matrix. |
IEA |
MF |
GO:0001609 |
G-protein coupled adenosine receptor activity |
Combining with adenosine and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. |
IEA |
MF |
GO:0001664 |
G-protein coupled receptor binding |
Interacting selectively and non-covalently with a G-protein coupled receptor. |
IEA |
MF |
GO:0001883 |
purine nucleoside binding |
Interacting selectively and non-covalently with a purine nucleoside, a compound consisting of a purine base linked either to ribose or deoxyribose. |
IEA |
MF |
GO:0004629 |
phospholipase C activity |
Catalysis of the reaction: a phospholipid + H2O = 1,2-diacylglycerol + a phosphatidate. |
IEA |
MF |
GO:0031072 |
heat shock protein binding |
Interacting selectively and non-covalently with a heat shock protein, any protein synthesized or activated in response to heat shock. |
IEA |
MF |
GO:0031683 |
G-protein beta/gamma-subunit complex binding |
Interacting selectively and non-covalently with a complex of G-protein beta/gamma subunits. |
IEA |
MF |
GO:0032795 |
heterotrimeric G-protein binding |
Interacting selectively and non-covalently with a heterotrimeric G-protein. |
IEA |
MF |
GO:0046982 |
protein heterodimerization activity |
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer. |
IEA |
Domain ID | Description |
---|---|
IPR000276 |
G protein-coupled receptor, rhodopsin-like |
IPR001068 |
Adenosine A1 receptor |
IPR001634 |
Adenosine receptor |
IPR017452 |
GPCR, rhodopsin-like, 7TM |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04022 |
cGMP-PKG signaling pathway |
KEGG |
hsa04024 |
cAMP signaling pathway |
KEGG |
hsa04071 |
Sphingolipid signaling pathway |
KEGG |
hsa04080 |
Neuroactive ligand-receptor interaction |
KEGG |
hsa04923 |
Regulation of lipolysis in adipocytes |
KEGG |
hsa04924 |
Renin secretion |
KEGG |
hsa05032 |
Morphine addiction |
KEGG |
WP455 |
GPCRs, Class A Rhodopsin-like |
WikiPathways |
WP80 |
Nucleotide GPCRs |
WikiPathways |
WP3594 |
Circadian rythm related genes |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0007370 |
Catalepsy |
C0007787 |
Transient Ischemic Attack |
C0013182 |
Drug Allergy |
C0020649 |
Hypotension |
C0022116 |
Ischemia |
C0027051 |
Myocardial Infarction |
C0027746 |
Nerve Degeneration |
C0033054 |
Prenatal Exposure Delayed Effects |
C0038525 |
Subarachnoid Hemorrhage |
C0038587 |
Substance Withdrawal Syndrome |
C0041755 |
Adverse Reaction To Drug |
C0242973 |
Ventricular Dysfunction |
C0428977 |
Bradycardia |
C0740392 |
Infarction, Middle Cerebral Artery |
Pubmed ID | Author | Year | Title |
---|---|---|---|
12734205 |
Wood et al. |
2003 |
The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray Analysis |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
ATXN1L |
342371 |
P0C7T5 |
0.63 |
ADA |
100 |
P00813 |
0.69 |
GNAS |
2778 |
P84996 |
0.52 |
GNAZ |
2781 |
P19086 |
0.63 |
SNF8 |
11267 |
Q96H20 |
0.63 |
GNAO1 |
2775 |
P09471 |
0.70 |
ADORA2A |
135 |
P29274 |
0.74 |
EPB41L2 |
2037 |
O43491 |
0.78 |
DRD1 |
1812 |
P21728 |
0.83 |
GRM1 |
2911 |
Q13255 |
0.83 |
GNAI2 |
2771 |
P04899 |
0.84 |
P2RY1 |
5028 |
P47900 |
0.89 |